BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 24122003)

  • 1. Admission neutrophil-lymphocyte ratio predicts 90 day outcome after endovascular stroke therapy.
    Brooks SD; Spears C; Cummings C; VanGilder RL; Stinehart KR; Gutmann L; Domico J; Culp S; Carpenter J; Rai A; Barr TL
    J Neurointerv Surg; 2014 Oct; 6(8):578-83. PubMed ID: 24122003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutrophil-to-Lymphocyte Ratio and Response to Intravenous Thrombolysis in Patients with Acute Ischemic Stroke.
    Pektezel MY; Yilmaz E; Arsava EM; Topcuoglu MA
    J Stroke Cerebrovasc Dis; 2019 Jul; 28(7):1853-1859. PubMed ID: 31072698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in neutrophil, lymphocyte, platelet ratios and their relationship with NIHSS after rtPA and/or thrombectomy in ischemic stroke.
    Kömürcü HF; Gözke E; Doğan Ak P; Kalyoncu Aslan I; Salt I; Özgenç Bi Er Çİ
    J Stroke Cerebrovasc Dis; 2020 Aug; 29(8):105004. PubMed ID: 32689579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
    Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
    J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase in neutrophils after recombinant tissue plasminogen activator thrombolysis predicts poor functional outcome of ischaemic stroke: a longitudinal study.
    Shi J; Peng H; You S; Liu Y; Xu J; Xu Y; Liu H; Shi R; Cao Y; Liu CF
    Eur J Neurol; 2018 Apr; 25(4):687-e45. PubMed ID: 29341345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic Neutrophil-Lymphocyte Ratios Predict Short-term Prognostic Outcome of Thrombolysis in Patients with Acute Ischemic Stroke.
    Weng Y; Hu J; Ren J; Huang H; Yang C; Shen J; Pan W; Sun F; Qiu H; Gao Y; Li S; Huang X; Chen G
    Neurotox Res; 2021 Oct; 39(5):1678-1687. PubMed ID: 34138446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
    Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
    Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Follow-up neutrophil-lymphocyte ratio after stroke thrombectomy is an independent biomarker of clinical outcome.
    Aly M; Abdalla RN; Batra A; Shaibani A; Hurley MC; Jahromi BS; Potts MB; Ansari SA
    J Neurointerv Surg; 2021 Jul; 13(7):609-613. PubMed ID: 32763917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of intravenous thrombolysis on MRI parameters and functional outcome in acute stroke <6 hours.
    Röther J; Schellinger PD; Gass A; Siebler M; Villringer A; Fiebach JB; Fiehler J; Jansen O; Kucinski T; Schoder V; Szabo K; Junge-Hülsing GJ; Hennerici M; Zeumer H; Sartor K; Weiller C; Hacke W;
    Stroke; 2002 Oct; 33(10):2438-45. PubMed ID: 12364735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety, effectiveness, and practicality of endovascular therapy within the first 3 hours of acute ischemic stroke onset.
    Mathews MS; Sharma J; Snyder KV; Natarajan SK; Siddiqui AH; Hopkins LN; Levy EI
    Neurosurgery; 2009 Nov; 65(5):860-5; discussion 865. PubMed ID: 19834397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microcatheter to recanalization (procedure time) predicts outcomes in endovascular treatment in patients with acute ischemic stroke: when do we stop?
    Hassan AE; Chaudhry SA; Miley JT; Khatri R; Hassan SA; Suri MF; Qureshi AI
    AJNR Am J Neuroradiol; 2013 Feb; 34(2):354-9. PubMed ID: 22821922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential leukocyte counts on admission predict outcomes in patients with acute ischaemic stroke treated with intravenous thrombolysis.
    Malhotra K; Goyal N; Chang JJ; Broce M; Pandhi A; Kerro A; Shahripour RB; Alexandrov AV; Tsivgoulis G
    Eur J Neurol; 2018 Dec; 25(12):1417-1424. PubMed ID: 29953701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
    Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High neutrophil-to-lymphocyte ratio is a predictor of poor short-term outcome in patients with mild acute ischemic stroke receiving intravenous thrombolysis.
    Liu YL; Wu ZQ; Qu JF; Qiu DH; Luo GP; Yin HP; Fang XW; Wang F; Chen YK
    Brain Behav; 2020 Dec; 10(12):e01857. PubMed ID: 32981201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic value of combined uric acid and neutrophil-to-lymphocyte ratio in acute ischemic stroke patients treated with intravenous thrombolysis.
    Wang C; Zhou M; Kang T; You S; Cao Y; Kong W; Shi J
    BMC Neurol; 2024 May; 24(1):183. PubMed ID: 38822243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Large-Vessel Occlusion Stroke: Effect of Recanalization on Outcome Depends on the National Institutes of Health Stroke Scale Score.
    Skagen K; Skjelland M; Russell D; Jacobsen EA
    J Stroke Cerebrovasc Dis; 2015 Jul; 24(7):1532-9. PubMed ID: 25922156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis.
    Adeoye O; Sucharew H; Khoury J; Tomsick T; Khatri P; Palesch Y; Schmit PA; Pancioli AM; Broderick JP;
    Stroke; 2015 Feb; 46(2):461-4. PubMed ID: 25523054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal dynamics of peripheral neutrophil and lymphocytes following acute ischemic stroke.
    Petrone AB; Eisenman RD; Steele KN; Mosmiller LT; Urhie O; Zdilla MJ
    Neurol Sci; 2019 Sep; 40(9):1877-1885. PubMed ID: 31069585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Inflammation Indices in Patients With Acute Ischemic Stroke Treated With Intravenous Tissue Plasminogen Activator: Clinical Yield and Utility.
    Topcuoglu MA; Pektezel MY; Yilmaz E; Arsava EM
    Angiology; 2021 Mar; 72(3):279-284. PubMed ID: 33153275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil-to-lymphocyte ratio in predicting neurologic outcome of patients with acute ischemic stroke treated with intravenous thrombolytics.
    Chen CT; Li LH; Su PY; Chang YC; Lee IH; Yen DH; How CK
    J Chin Med Assoc; 2022 Jan; 85(1):102-108. PubMed ID: 34380992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.